Investigational Drug Steering Committee Roster
The Investigational Drug Steering Committee (IDSC) collaborates with the NCI in the design and prioritization of early phase drug development trials carried out within the Experimental Therapeutics Clinical Trials Network (ETCTN) with agents for which NCI’s Cancer Therapy and Evaluation Program (CTEP) holds an Investigational New Drug (IND) application. The IDSC's membership comprises Principal Investigators of CTEP’s Phase 1 U01 and Phase 2 early drug development grants, NCTN group representatives, subject matter experts in trial design, clinical imaging, radiation therapy, pharmacokinetics/pharmacodynamics, cancer omics, health-related quality of life, and biostatistics, as well as patient advocates and NCI staff.
Co-chairs
Patricia M. LoRusso, D.O.
Yale University
New Haven, CT
Geoffrey I. Shapiro M.D., Ph.D.
Dana-Farber Cancer Institute
Boston, MA
Members
Carol Aghajanian, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Susanne Arnold, M.D.
University of Kentucky
Lexington, KY
Philippe Bedard, M.D., FRCPC
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Chandra Belani, M.D.
Pennsylvania State University Cancer Institute
Hershey, PA
Jordan Berlin, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Jan Beumer, Pharm.D., Ph.D.
University of Pittsburgh Cancer Institute
Pittsburgh, PA
Michael Carducci, M.D.
Johns Hopkins University
Baltimore, MD
William Carson, M.D.
Ohio State University Medical Center
Columbus, OH
A. Dimitrios Colevas, M.D.
Stanford University
Stanford, CA
Brian A. Costello, M.D.
Mayo Clinic
Rochester, MN
Kevin Courtney, M.D., Ph.D.
University of Texas Southwestern Medical Center
Dallas, TX
Elizabeth Claire Dees, M.D., M.Sc., Sc.M.
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Adam Dicker, M.D., Ph.D., FASTRO
Thomas Jefferson University
Philadelphia, PA
S. Gail Eckhardt, M.D.
University of Texas at Austin
Austin, TX
Keith T. Flaherty, M.D.
Massachusetts General Hospital
Boston, MA
David R. Gandara, M.D.
University of California Davis Comprehensive Cancer Center
Sacramento, CA
Ignacio Garrido-Laguna, M.D., Ph.D.
University of Utah Huntsman Cancer Institute
Salt Lake City, UT
Ryan Gentzler, M.D.
University of Virginia
Charlottesville, VA
Ivana Gojo, M.D.
Johns Hopkins University
Baltimore, MD
Steven Grant, M.D.
Virginia Commonwealth University
Richmond, VA
Salma Jabbour, M.D.
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ
V. Suzanne Klimberg, M.D., Ph.D.
University of Texas Medical Branch at Galveston
Galveston, TX
Donald W. Kufe, M.D.
Dana-Farber Cancer Institute
Boston, MA
Jeffrey Lancet, M.D.
University of South Florida H. Lee Moffitt Cancer Center
Tampa, FL
Primo Lara, M.D.
University of California Davis Comprehensive Cancer Center
Sacramento, CA
Steven Larson, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Heinz-Josef Lenz, M.D.
University of Southern California Norris Comprehensive Cancer Center
Los Angeles, CA
Glenn Liu, M.D.
University of Wisconsin Comprehensive Cancer Center
Madison, WI
Jason Luke, M.D., FACP
University of Pittsburgh Hillman Cancer Center
Pittsburgh, PA
Devalingam Mahalingam, M.B. B.CH. B.A.O Ph.D.
Northwestern University Feinberg School of Medicine
Chicago, IL
Funda Meric-Bernstam, M.D.
University of Texas MD Anderson Cancer Center
Houston, TX
Wells Messersmith, M.D., Ph.D.
University of Colorado
Aurora, CO
Kathleen Moore, M.D.
University of Oklahoma Stephenson Cancer Center
Oklahoma City, OK
Edward Newman, Ph.D.
City of Hope Beckman Research Institute
Duarte, CA
Taofeek Owonikoko, M.D., Ph.D.
University of Pittsburgh Hillman Cancer Center
Pittsburgh, PA
Amit Oza, M.D., M.B.B.S., FRCPC
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
John Perentesis, M.D., FAAP
Cincinnati Children's Hospital
Cincinnati, OH
Gina R. Petroni, Ph.D.
University of Virginia
Charlottesville, VA
Michelle Rudek-Renaut, Pharm.D., Ph.D.
Johns Hopkins University
Baltimore, MD
Gary K. Schwartz, M.D.
Columbia University Medical Center
New York, NY
Lesley Seymour, M.D., FRCPC
Queen's University
Kingston, ON, Canada
Yu Shyr, Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Lillian L. Siu, M.D.
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Jeffrey L. Sklar, M.D., Ph.D.
Yale Cancer Center
New Haven, CT
Patricia Spears
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Richard J. Vetter, Ph.D.
Mayo Clinic
Rochester, MN
Miguel Villalona-Calero, M.D.
City of Hope Comprehensive Cancer Center
Duarte, CA
Liza C. Villaruz, M.D.
University of Pittsburgh Hillman Cancer Center
Pittsburgh, PA
Brenda Weigel, M.D.
University of Minnesota
Minneapolis, MN
Patrick Y. Wen, M.D.
Dana-Farber Cancer Institute
Boston, MA
James Yao, M.D.
University of Texas MD Anderson Cancer Center
Houston, TX
NCI CCCT Program Director
Steven Reeves, Ph.D.
steven.reeves@nih.gov